- Sample size - it mentions that the sample is fairly small - a couple of hundred people
- Succes rate - it mentions that around 40% of people were migraine free after two hours
- It mentions that the success rate was distinctly different from the placebo (though doesn't say what success the placebo had)
- It gives a decent outline of the problem and the solution.
It's nice to see articles like this. This particular one is well outside my field, but I can see that important points are included. One of the big problems with reporting I find is that things are often touted as cures or solved problems, when there may still be a significant degree of uncertainty, which is not put across well. Top marks for this article.